Scholarlink

<p>Acinetobacter baumannii, a robust Gram-negative bacterium known for causing nosocomial infections, exhibiting multidrug resistance, and lacking antimicrobial peptides that target it, remains hard to treat. Here, we report a few-shot learning pipeline integrating classification, ranking, and regression modules. Each module is trained via a few-shot learning strategy involving pre-training and multiple fine-tuning steps, incorporating similar and true data for fine-tuning, to identify potent AMPs against Acinetobacter baumannii. This pipeline effectively scans complete libraries of hexapeptides, heptapeptides, and octapeptides (encompassing tens of billions of candidates) despite the extreme scarcity of training data. Results show it discovers AMPs active against Acinetobacter baumannii and Candida albicans, with low off-target toxicity and negligible drug resistance susceptibility. Additionally, EME7(7) controls Acinetobacter baumannii pneumonia in mice without kidney injury, a contrast to the observed effects of polymyxin B. This work provides a paradigm for addressing challenges of limited data availability.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Discovery of antimicrobial peptides targeting Acinetobacter baumannii via a pre-trained and fine-tuned few-shot learning-based pipeline

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月7日

查看全文
  • Junjie Huang,
  • Wentao Zhang,
  • Aowen Wang,
  • Yunzhi Jiang,
  • Yuxian Lai,
  • Yanchao Xu,
  • Cong Wang,
  • Junbo Zhao,
  • Peng Zhang,
  • Jian Ji

摘要

Acinetobacter baumannii, a robust Gram-negative bacterium known for causing nosocomial infections, exhibiting multidrug resistance, and lacking antimicrobial peptides that target it, remains hard to treat. Here, we report a few-shot learning pipeline integrating classification, ranking, and regression modules. Each module is trained via a few-shot learning strategy involving pre-training and multiple fine-tuning steps, incorporating similar and true data for fine-tuning, to identify potent AMPs against Acinetobacter baumannii. This pipeline effectively scans complete libraries of hexapeptides, heptapeptides, and octapeptides (encompassing tens of billions of candidates) despite the extreme scarcity of training data. Results show it discovers AMPs active against Acinetobacter baumannii and Candida albicans, with low off-target toxicity and negligible drug resistance susceptibility. Additionally, EME7(7) controls Acinetobacter baumannii pneumonia in mice without kidney injury, a contrast to the observed effects of polymyxin B. This work provides a paradigm for addressing challenges of limited data availability.